Product List
Ribociclib intermediate 4 | 1211443-58-1
"
Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is……
Brigatinib Intermediate 4 | 1197953-49-3
"
Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib intermediate 1 | 1089279-91-3
"
Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib intermediate 3 | 761440-75-9
"
Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Brigatinib Intermediate 2 | 1089279-90-2
"
Brigatinib is an investigational small-molecule targeted cancer therapy. It acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth f……
Abemaciclib Intermediate 1 | 1231930-42-9
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 2 | 1180132-17-5
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 3 | 1231930-37-2
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……
Abemaciclib Intermediate 4 | 1231930-33-8
"
Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly. and it acts as a CDK inhibitor se……